Grid Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- September 14, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founders
- Edward F. Patz, Jr. MD
- Company Description
- Grid develops an innovative platform to develop human derived antibodies focusing on cancer therapeutics.
- Market
- Cancer Immunotherapy
- Location
- Durham, North Carolina, USA
- Coinvestors
- Duke University, Longview International